Abstract
Branched chain amino acids (BCAA) may facilitate tumor growth; consequently, it is reasonable to assume that the dietary intake of BCAA may play a role in bladder carcinogenesis. To date, however, there is no epidemiological data relevant to a relationship of dietary BCAA with the risk of bladder cancer. On the other hand, there are a few experimental studies reported in the literature. This chapter focuses on the studies evaluating the effects of l-isoleucine and l-leucine on bladder carcinogenesis in experimental animals. These three studies employed a two-stage (initiation–promotion) carcinogenesis protocol with male F344 rats. The results show that the effects of dietary BCAA on rat bladder carcinogenesis is dependent on the type of basal diet used.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nishio Y, Kakizoe T, Ohtani M, Sato S, Sugimura T, Fukushima S. L-isoleucine and L-leucine: tumor promoters of bladder cancer in rats. Science. 1986;231:843–5.
Xie XL, Wei M, Yunoki T, Kakehashi A, Yamano S, Kato M, Wanibuchi H. Long-term treatment with L-isoleucine or L-leucine in AIN-93G diet has promoting effects on rat bladder carcinogenesis. Food Chem Toxicol. 2012;50:3934–40.
Fukushima S, Shibata MA, Kurata Y, Hasegawa R. The roles of L-ascorbic acid, urinary pH, and Na or K ion concentration in rat bladder epithelial cell proliferation with special reference to tumor promotion. Prog Clin Biol Res. 1991;369:195–208.
Clayson DB, Fishbein L, Cohen SM. Effects of Stones and Other Physical Factors on the Induction of Rodent Bladder-Cancer. Food Chem Toxicol. 1995;33:771–84.
Xie XL, Kakehashi A, Wei M, Yamano S, Takeshita M, Yunoki T, Wanibuchi H. L-Leucine and L-isoleucine enhance tumor growth of BBN-induced urothelial tumors in the rat bladder by modulating expression of amino acid transporters and tumorigenesis-associated genes. Food Chem Toxicol. 2013;59:137–44.
Babu E, Kanai Y, Chairoungdua A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamoto S, Anzai N, Nagamori S, Endou H. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003;278:43838–45.
Bodoy S, Martin L, Zorzano A, Palacin M, Estevez R, Bertran J. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem. 2005;280:12002–11.
Del Amo EM, Urtti A, Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci. 2008;35:161–74.
Baracos VE, Mackenzie ML. Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr. 2006;136:237S–42.
Luo X, Yin P, Reierstad S, Ishikawa H, Lin Z, Pavone ME, Zhao H, Marsh EE, Bulun SE. Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4 F2 heavy chain expression in uterine leiomyoma cells. J Clin Endocrinol Metab. 2009;94:4533–9.
Wang Q, Bailey CG, Ng C, Tiffen J, Thoeng A, Minhas V, Lehman ML, Hendy SC, Buchanan G, Nelson CC, Rasko JE, Holst J. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Res. 2011;71:7525–36.
Kobayashi H, Ishii Y, Takayama T. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol. 2005;90:233–8.
Miyamoto YJ, Mitchell JS, McIntyre BW. Physical association and functional interaction between beta1 integrin and CD98 on human T lymphocytes. Mol Immunol. 2003;39:739–51.
Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann Surg Oncol. 2009;16:3473–81.
Protein and amino acid requirements in human nutrition. World Health Organ Tech Rep Ser. 2007: 1–265, back cover.
Tayek JA, Bistrian BR, Hehir DJ, Martin R, Moldawer LL, Blackburn GL. Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia. A prospective randomized crossover trial. Cancer. 1986;58:147–57.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wei, M., Xie, XL., Yamano, S., Kakehashi, A., Wanibuchi, H. (2015). Isoleucine, Leucine and Their Role in Experimental Models of Bladder Carcinogenesis. In: Rajendram, R., Preedy, V., Patel, V. (eds) Branched Chain Amino Acids in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1923-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1923-9_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1922-2
Online ISBN: 978-1-4939-1923-9
eBook Packages: MedicineMedicine (R0)